NCT06550570 Evaluation of the Impact of Ambulatory Epidural on Maternal Satisfaction During Delivery and Postpartum
| NCT ID | NCT06550570 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Régional Metz-Thionville |
| Condition | Childbirth |
| Study Type | OBSERVATIONAL |
| Enrollment | 126 participants |
| Start Date | 2024-07-23 |
| Primary Completion | 2026-07-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 126 participants in total. It began in 2024-07-23 with a primary completion date of 2026-07-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Childbirth is a special event for women. Maternal satisfaction regarding childbirth is quite important, that is why this factor has to be taken into account. A bad experience related to childbirth could lead to serious psychological and organic consequences such as postpartum depression, mother-baby bond deterioration and chronic pelvic pain. Childbirth image changed over the years to the extent that an increasingly physiological process keeping analgesia and safety is more and more desired. In this perspective, this study aims to investigate an approach so-called ambulatory epidural. Indeed, only a few studies have been conducted and the ones published in 1990s did not involve the current recommended pharmacological protocols.
Eligibility Criteria
Inclusion Criteria: * Women older than 18 years old * with Physiological pregnancy (fetus cephalic position, normal fetal heart rate, spontaneous work between 37 and 41 SA) * Having benefited from epidural, usual or ambulatory depending on the study period * who speeks and understand French * who signed a free and informed consent form Exclusion Criteria: * Hearing or comprehension impairment * Twin pregnancies * Scarred uterus * Fetus in non cephalic position * Imminent delivery * Women under protective supervision (guardianship, curatorship) * Women bereaved of a spouse or child during pregnancy * Hospitalization of child in neonatology after delivery * Women hospitalized in critical care units after childbirth
Contact & Investigator
Lisa LEON, MD
PRINCIPAL INVESTIGATOR
CHR Metz Thionville Hopital Femme Mère Enfant
Frequently Asked Questions
Who can join the NCT06550570 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Childbirth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06550570 currently recruiting?
Yes, NCT06550570 is actively recruiting participants. Contact the research team at projet-recherche-clinique@chr-metz-thionville.fr for enrollment information.
Where is the NCT06550570 trial being conducted?
This trial is being conducted at Metz, France, Thionville, France.
Who is sponsoring the NCT06550570 clinical trial?
NCT06550570 is sponsored by Centre Hospitalier Régional Metz-Thionville. The principal investigator is Lisa LEON, MD at CHR Metz Thionville Hopital Femme Mère Enfant. The trial plans to enroll 126 participants.